Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Divison of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
J Infect Public Health. 2020 Aug;13(8):1166-1171. doi: 10.1016/j.jiph.2020.01.314. Epub 2020 Apr 7.
The infectious complications in hemodialysis patients are still among the main reasons for their increased morbidity and mortality. The possible reasons behind this might be due to impairments in the host defense mechanisms, comorbidities, invasive procedures and pathogenicity of the infecting organisms. With the increased incidence of bacteremia in hemodialysis patients and the overt use of antibiotics, we have witnessed a rise in the number of new multidrug resistant (MDR) strains in those patients.
We aim to determine the epidemiology, risk factors and complications of infections in patients receiving chronic hemodialysis, particularly bloodstream infections.
This is a retrospective case-control study involving patients undergoing hemodialysis at a tertiary care center. We studied the prevalence of infectious complications among those patients as well as the responsible agent in each respective infectious episode and the risk factors associated with bacteremia.
46.6% of the studied population had at least one documented episode of infection. The most common were blood and respiratory infections (33.2% and 32.7% respectively). Among patients with bacteremia, coagulase-negative Staphylococcus was the predominant pathogen (49% of cases), followed by Staphylococcus aureus and Escherichia coli. Mortality was higher in patients who had MDR bacteremia, and in those who had mechanical ventilation or intensive care unit (ICU) admission.
Due to the alarming increase in the incidence of infection among hemodialysis patients and its strong association with mortality, further studies are needed to look for risk factors associated with infection and for ways to control those risk factors.
血液透析患者的感染并发症仍然是其发病率和死亡率增加的主要原因之一。造成这种情况的可能原因是宿主防御机制受损、合并症、有创操作和感染病原体的致病性。随着血液透析患者菌血症发病率的增加和抗生素的过度使用,我们已经看到这些患者中新型多药耐药(MDR)菌株的数量有所增加。
我们旨在确定接受慢性血液透析治疗的患者(尤其是血液感染患者)感染的流行病学、危险因素和并发症。
这是一项在三级护理中心进行的回顾性病例对照研究。我们研究了这些患者中感染并发症的流行情况以及每个感染事件中的致病因子以及与菌血症相关的危险因素。
研究人群中有 46.6%至少有一次记录在案的感染事件。最常见的是血液和呼吸道感染(分别为 33.2%和 32.7%)。在菌血症患者中,凝固酶阴性葡萄球菌是主要病原体(占 49%),其次是金黄色葡萄球菌和大肠杆菌。患有 MDR 菌血症的患者以及接受机械通气或重症监护病房(ICU)治疗的患者死亡率更高。
由于血液透析患者感染发生率的惊人增加及其与死亡率的强烈关联,需要进一步研究以寻找与感染相关的危险因素,并寻找控制这些危险因素的方法。